NEXGEL to Report Third Quarter 2024 Financial Results on November 13th

11/11/24 9:00:00 AM ET

Medical/Dental Instruments

Health Care

Get the next $NXGL alert in real time by email

Management will host a conference call at 4:30 P.M. ET on the same day

LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the third quarter 2024, after the market close on November 13, 2024. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.

Third Quarter 2024 Financial Results Conference Call

Date: November 13, 2024

Time: 4:30 P.M. ET

Live Call: 1-800-225-9448 (U.S. Toll Free) or 1-203-518-9708 (International)

Webcast: Events and Presentations

For interested individuals unable to join the conference call, a replay will be available through August 28, 2024 by dialing + 1-844-512-2921 (U.S. Toll Free) or + 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11157563. An archived version of the webcast will also be available for 90 days.

About NEXGEL, INC.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal^®, Hexagels^®, Turfguard^®, Kenkoderm^® and Silly George^®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contacts:

Valter Pinto, Managing Director

KCSA Strategic Communications

212.896.1254

[email protected]

Get the next $NXGL alert in real time by email

Date

Price Target

Rating

Analyst

2/25/2022

$6.00

Buy

Maxim Group

NEXGEL to Report Third Quarter 2024 Financial Results on November 13th

Chat with this insight

Recent Analyst Ratings for
$NXGL

$NXGL
Market Insights

Live Market Insights

NEXGEL And Innovative Optics US Initiate IRB Study In Accordance With FDA Of Hydrogel Application During Laser Hair Removal

Helen of Troy, SMART Global And 3 Stocks To Watch Heading Into Tuesday

NexGel Says The Growth We Expect In Second Half Of This Year Positions Us Well To Move To Positive Cash Flow From Operations

$NXGL
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Levy Adam R. bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 1% to 333,196 units (SEC Form 4)

Director Zeldis Jerome B bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 4% to 106,664 units (SEC Form 4)

Director Stein John Nachum gifted 4,000 shares and bought $9,999 worth of shares (3,636 units at $2.75), decreasing direct ownership by 0.08% to 471,456 units (SEC Form 4)

$NXGL
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Levy Adam R. bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 1% to 333,196 units (SEC Form 4)

Director Zeldis Jerome B bought $9,999 worth of shares (3,636 units at $2.75), increasing direct ownership by 4% to 106,664 units (SEC Form 4)

Director Stein John Nachum gifted 4,000 shares and bought $9,999 worth of shares (3,636 units at $2.75), decreasing direct ownership by 0.08% to 471,456 units (SEC Form 4)

$NXGL
SEC Filings

SEC Form 10-Q filed by NexGel Inc

SEC Form 424B5 filed by NexGel Inc

NexGel Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement

$NXGL
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Maxim Group initiated coverage on NexGel with a new price target

$NXGL
Press Releases

Fastest customizable press release news feed in the world

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

NEXGEL Announces $2,000,000 Registered Direct Offering

$NXGL
Leadership Updates

Live Leadership Updates

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board

$NXGL
Financials

Live finance-specific insights